The invention relates to novel compounds which show highaffinity for cocaine receptors in the brain, particularly dopamineand serotonin transporter sites. The compounds may be used asimaging or pharmaceutical agents, in the diagnosis and treatment ofdrug addiction, depression, anorexia and neurodegenerativediseases.
Cocaine receptor binding ligands
Kuhar, MJ., Carroll, F., Boja, JW., Lewin, A., & Abraham, P. (2003). IPC No. U.S. Cocaine receptor binding ligands. (U.S. Patent No. 6531483). http://patft.uspto.gov/netacgi/nph-Parser?patentnumber=6531483
Abstract
Abstract
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.